(Circulation. 1995;92:1499-1506.)
© 1995 American Heart Association, Inc.
Articles |
Double-Blind, Placebo-Controlled Study of the Long-term Efficacy of Carvedilol in Patients With Severe Chronic Heart Failure
From the Division of Circulatory Physiology and Center for Heart Failure Research, Columbia University, College of Physicians and Surgeons, and the Division of Cardiology, Mount Sinai School of Medicine, New York, NY.
Background Clinical trials have shown that ß-adrenergic blocking drugs are effective and well tolerated in patients with mild to moderate heart failure, but the utility and safety of these drugs in patients with advanced disease have not been evaluated.
Methods and Results We enrolled 56 patients with severe chronic heart failure into a double-blind, placebo-controlled study of the vasodilating ß-blocker carvedilol. All patients had advanced heart failure, as evidenced by a mean left ventricular ejection fraction of 0.16±0.01 and a mean maximal oxygen consumption of 13.6±0.6 mL · kg-1 · min-1 despite digitalis, diuretics, and an angiotensin-converting enzyme inhibitor (if tolerated). After a 3-week, open-label, up-titration period, 49 of the 56 patients were assigned (in a double-blind fashion using a 2:1 randomization) to receive either carvedilol (25 mg BID, n=33) or matching placebo (n=16) for 14 weeks, while background therapy remained constant. Hemodynamic and functional variables were measured at the start and end of the study. Compared with the placebo group, patients in the carvedilol group showed improved cardiac performance, as reflected by an increase in left ventricular ejection fraction (P=.005) and stroke volume index (P=.010) and a decrease in pulmonary wedge pressure, mean right atrial pressure, and systemic vascular resistance (P=.003, .002, and .017, respectively). In addition, compared with placebo, patients treated with carvedilol benefited clinically, as shown by an improvement in symptom scores (P=.002), functional class (P=.013), and submaximal exercise tolerance (P=.006). The combined risk of death, worsening heart failure, and life-threatening ventricular tachyarrhythmia was lower in the carvedilol group than in the placebo group (P=.028), but carvedilol-treated patients had more dizziness and advanced heart block.
Conclusions Carvedilol produces clinical and hemodynamic improvement in patients who have severe heart failure despite treatment with angiotensin-converting enzyme inhibitors.
Key Words: heart failure • carvedilol • receptors, adrenergic, beta
This article has been cited by other articles:
 |
|
 |
|
  D. Domanski and E. R. Schwarz Clinical Review: Is the Perioperative Use of {beta}-Blockers Still Recommended? A Critical Review of Recent Controversies Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2009; 14(4): 258 - 268. [Abstract] [PDF]
|
|
|
|
 |
|
 S. J. Goodlin Palliative care in congestive heart failure. J. Am. Coll. Cardiol., July 28, 2009; 54(5): 386 - 396. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Hunt, W. T. Abraham, M. H. Chin, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. Jessup, M. A. Konstam, D. M. Mancini, K. Michl, et al. 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation J. Am. Coll. Cardiol., April 14, 2009; 53(15): e1 - e90. [Full Text] [PDF]
|
|
|
|
|
|
M. Jessup, W. T. Abraham, D. E. Casey, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. A. Konstam, D. M. Mancini, P. S. Rahko, M. A. Silver, et al. 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation J. Am. Coll. Cardiol., April 14, 2009; 53(15): 1343 - 1382. [Full Text] [PDF]
|
|
|
|
 |
|
 2009 WRITING GROUP TO REVIEW NEW EVIDENCE AND UPDA, M. Jessup, W. T. Abraham, D. E. Casey, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. A. Konstam, D. M. Mancini, P. S. Rahko, et al. 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation Circulation, April 14, 2009; 119(14): 1977 - 2016. [Full Text] [PDF]
|
|
|
|
|
|
2005 WRITING COMMITTEE MEMBERS, S. A. Hunt, W. T. Abraham, M. H. Chin, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. Jessup, M. A. Konstam, D. M. Mancini, et al. 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation Circulation, April 14, 2009; 119(14): e391 - e479. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Dobre, D. J. van Veldhuisen, M. J.L. DeJongste, C. Lucas, G. Cleuren, R. Sanderman, A. V. Ranchor, and F. M. Haaijer-Ruskamp Prescription of beta-blockers in patients with advanced heart failure and preserved left ventricular ejection fraction. Clinical implications and survival Eur J Heart Fail, March 1, 2007; 9(3): 280 - 286. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Abdulla, L. Kober, E. Christensen, and C. Torp-Pedersen Effect of beta-blocker therapy on functional status in patients with heart failure -- A meta-analysis Eur J Heart Fail, August 1, 2006; 8(5): 522 - 531. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Passantino, R. Lagioia, F. Mastropasqua, and D. Scrutinio Short-Term Change in Distance Walked in 6 Min Is an Indicator of Outcome in Patients With Chronic Heart Failure in Clinical Practice J. Am. Coll. Cardiol., July 4, 2006; 48(1): 99 - 105. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Funck-Brentano Beta-blockade in CHF: from contraindication to indication Eur. Heart J. Suppl., June 1, 2006; 8(suppl_C): C19 - C27. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Developed in Collaboration With the American Colle, Endorsed by the Heart Rhythm Society, S. A. Hunt, W. T. Abraham, M. H. Chin, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. Jessup, M. A. Konstam, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult--Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) J. Am. Coll. Cardiol., September 20, 2005; 46(6): 1116 - 1143. [Full Text] [PDF]
|
|
|
|
 |
|
 L. G. Olsson, K. Swedberg, A. L. Clark, K. K. Witte, and J. G.F. Cleland Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review Eur. Heart J., April 2, 2005; 26(8): 778 - 793. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Faggiano, A. D'Aloia, A. Gualeni, L. Brentana, and L. D. Cas The 6 minute walking test in chronic heart failure: indications, interpretation and limitations from a review of the literature Eur J Heart Fail, October 1, 2004; 6(6): 687 - 691. [Full Text] [PDF]
|
|
|
|
|
|
T. E. Sirak, S. Jelic, and T. H. Le Jemtel Therapeutic update: Non-selective beta- and alpha-adrenergic blockade in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure J. Am. Coll. Cardiol., August 4, 2004; 44(3): 497 - 502. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N G Bellenger, K Rajappan, S L Rahman, A Lahiri, U Raval, J Webster, G D Murray, A J S Coats, J G F Cleland, and D J Pennell Effects of carvedilol on left ventricular remodelling in chronic stable heart failure: a cardiovascular magnetic resonance study Heart, July 1, 2004; 90(7): 760 - 764. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zanolla and P. Zardini Selection of endpoints for heart failure clinical trials Eur J Heart Fail, December 1, 2003; 5(6): 717 - 723. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K K A Witte, S D R Thackray, N P Nikitin, J G F Cleland, and A L Clark The effects of {alpha} and {beta} blockade on ventilatory responses to exercise in chronic heart failure Heart, October 1, 2003; 89(10): 1169 - 1173. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Hryniewicz, A. S. Androne, A. Hudaihed, and S. D. Katz Comparative Effects of Carvedilol and Metoprolol on Regional Vascular Responses to Adrenergic Stimuli in Normal Subjects and Patients With Chronic Heart Failure Circulation, August 26, 2003; 108(8): 971 - 976. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bouzamondo, J.-S. Hulot, P. Sanchez, and P. Lechat Beta-blocker benefit according to severity of heart failure Eur J Heart Fail, June 1, 2003; 5(3): 281 - 289. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Houser and K. B. Margulies Is Depressed Myocyte Contractility Centrally Involved in Heart Failure? Circ. Res., March 7, 2003; 92(4): 350 - 358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Vittorio, C. C. Lang, S. D. Katz, M. Packer, D. M. Mancini, and U. P. Jorde Vasopressor Response to Angiotensin II Infusion in Patients With Chronic Heart Failure Receiving {beta}-Blockers Circulation, January 21, 2003; 107(2): 290 - 293. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Azeka, J. A. Franchini Ramires, C. Valler, and E. Alcides Bocchi Delisting of infants and children from the heart transplantation waiting list after carvedilol treatment J. Am. Coll. Cardiol., December 4, 2002; 40(11): 2034 - 2038. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Agostoni, M. Guazzi, M. Bussotti, S. De Vita, and P. Palermo Carvedilol Reduces the Inappropriate Increase of Ventilation During Exercise in Heart Failure Patients Chest, December 1, 2002; 122(6): 2062 - 2067. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Palazzuoli, F. Bruni, L. Puccetti, M. Pastorelli, P. Angori, A.L. Pasqui, and A. Auteri Effects of carvedilol on left ventricular remodeling and systolic function in elderly patients with heart failure Eur J Heart Fail, December 1, 2002; 4(6): 765 - 770. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Califf and D. L. DeMets Principles From Clinical Trials Relevant to Clinical Practice: Part I Circulation, August 20, 2002; 106(8): 1015 - 1021. [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Pritchett and M. M. Redfield {beta}-Blockers: New Standard Therapy for Heart Failure Mayo Clin. Proc., August 1, 2002; 77(8): 839 - 846. [Abstract] [PDF]
|
|
|
|
 |
|
 P. Merlet, L. Hittinger, J. L. Dubois-Rande, and A. Castaigne Myocardial Adrenergic Dysinnervation in Dilated Cardiomyopathy: Cornerstone or Epiphenomenon? J. Nucl. Med., April 1, 2002; 43(4): 536 - 539. [Full Text] [PDF]
|
|
|
|
|
|
K. Stoschitzky Beta-blockers in chronic heart failure Eur. Heart J., March 1, 2002; 23(5): 426 - 426. [Full Text] [PDF]
|
|
|
|
 |
|
 Yuejin Yang, Yida Tang, Yingmao Ruan, Yongli Li, Yanwen Zhou, Runlin Gao, Jilin Chen, and Zaijia Chen Comparative effects of cilazapril, carvedilol and their combination in preventing from left ventricular remodelling after acute myocardial infarction in rats Journal of Renin-Angiotensin-Aldosterone System, March 1, 2002; 3(1): 31 - 35. [Abstract] [PDF]
|
|
|
|
|
|
W. Remme and K. Swedberg A reply Eur. Heart J., March 1, 2002; 23(5): 426 - 427. [Full Text] [PDF]
|
|
|
|
|
|
S. Capomolla, G. Pinna, O. Febo, A. Caporotondi, G. Guazzotti, M. T. La Rovere, M. Gnemmi, A. Mortara, R. Maestri, and F. Cobelli Echo-Doppler mitral flow monitoring: an operative tool to evaluate day-to-day tolerance to and effectiveness of beta-adrenergic blocking agent therapy in patients with chronic heart failure J. Am. Coll. Cardiol., November 15, 2001; 38(6): 1675 - 1684. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kubo, E. R. Azevedo, G. E. Newton, J. D. Parker, and J. S. Floras Lack of evidence for peripheral alpha1- adrenoceptor blockade during long-term treatment of heart failure with carvedilol J. Am. Coll. Cardiol., November 1, 2001; 38(5): 1463 - 1469. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Shibata, M. D. Flather, and D. Wang Systematic review of the impact of beta blockers on mortality and hospital admissions in heart failure Eur J Heart Fail, June 1, 2001; 3(3): 351 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Brophy, L. Joseph, and J. L. Rouleau {beta}-Blockers in Congestive Heart Failure: A Bayesian Meta-Analysis Ann Intern Med, April 3, 2001; 134(7): 550 - 560. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C Opasich, G.D Pinna, A Mazza, O Febo, R Riccardi, P.G Riccardi, S Capomolla, G Forni, F Cobelli, and L Tavazzi Six-minute walking performance in patients with moderate-to-severe heart failure; is it a useful indicator in clinical practice? Eur. Heart J., March 2, 2001; 22(6): 488 - 496. [Abstract] [PDF]
|
|
|
|
|
|
T. M. Ramahi, M. D. Longo, A. R. Cadariu, K. Rohlfs, S. A. Carolan, K. M. Engle, H. Samady, and F. J. T. Wackers Left ventricular inotropic reserve and right ventricular function predict increase of left ventricular ejection fraction after beta-blocker therapy in nonischemic cardiomyopathy J. Am. Coll. Cardiol., March 1, 2001; 37(3): 818 - 824. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Cice, L. Ferrara, A. Di Benedetto, P. E. Russo, G. Marinelli, F. Pavese, and A. Iacono Dilated cardiomyopathy in dialysis patients--beneficial effects of carvedilol: a double-blind, placebo-controlled trial J. Am. Coll. Cardiol., February 1, 2001; 37(2): 407 - 411. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. Dargie and The CAPRICORN Steering Committee Design and methodology of the CAPRICORN trial -- a randomised double blind placebo controlled study of the impact of carvedilol on morbidity and mortality in patients with left ventricular dysfunction after myocardial infarction Eur J Heart Fail, September 1, 2000; 2(3): 325 - 332. [Full Text] [PDF]
|
|
|
|
|
|
G. Cice, E. Tagliamonte, L. Ferrara, and A. Iacono Efficacy of carvedilol on complex ventricular arrhythmias in dilated cardiomyopathy: double-blind, randomized, placebo-controlled study Eur. Heart J., August 1, 2000; 21(15): 1259 - 1264. [Abstract] [PDF]
|
|
|
|
|
|
M. R. Bristow What Type of {beta}-Blocker Should Be Used to Treat Chronic Heart Failure? Circulation, August 1, 2000; 102(5): 484 - 486. [Full Text] [PDF]
|
|
|
|
|
|
W. Nieuwland, M. A. Berkhuysen, D. J. van Veldhuisen, J. Brugemann, M. L. J. Landsman, E. van Sonderen, K. I. Lie, H. J. G. M. Crijns, and P. Rispens Differential effects of high-frequency versus low-frequency exercise training in rehabilitation of patients with coronary artery disease J. Am. Coll. Cardiol., July 1, 2000; 36(1): 202 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Wei, L. T. C. Chow, and J. E. Sanderson Effect of carvedilol in comparison with metoprolol on myocardial collagen postinfarction J. Am. Coll. Cardiol., July 1, 2000; 36(1): 276 - 281. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Genth-Zotz, R. J. Zotz, M. Sigmund, P. Hanrath, D. Hartmann, M. Bohm, F. Waagstein, N. Treese, J. Meyer, and H. Darius MIC trial: metoprolol in patients with mild to moderate heart failure: effects on ventricular function and cardiopulmonary exercise testing Eur J Heart Fail, June 1, 2000; 2(2): 175 - 181. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. T. Abraham {beta}-Blockers: The New Standard of Therapy for Mild Heart Failure Arch Intern Med, May 8, 2000; 160(9): 1237 - 1247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bonet, A. Agusti, J. M. Arnau, X. Vidal, E. Diogene, E. Galve, and J.-R. Laporte {beta}-Adrenergic Blocking Agents in Heart Failure: Benefits of Vasodilating and Nonvasodilating Agents According to Patients' Characteristics: A Meta-analysis of Clinical Trials Arch Intern Med, March 13, 2000; 160(5): 621 - 627. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Bristow {beta}-Adrenergic Receptor Blockade in Chronic Heart Failure Circulation, February 8, 2000; 101(5): 558 - 569. [Full Text] [PDF]
|
|
|
|
|
|
M. L. Kukin, M. M. Mannino, R. S. Freudenberger, J. Kalman, C. Buchholz-Varley, and O. Ocampo Hemodynamic comparison of twice daily metoprolol tartrate with once daily metoprolol succinate in congestive heart failure J. Am. Coll. Cardiol., January 1, 2000; 35(1): 45 - 50. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P S Macdonald, A M Keogh, C Aboyoun, M Lund, R Amor, and D McCaffrey Impact of concurrent amiodarone treatment on the tolerability and efficacy of carvedilol in patients with chronic heart failure Heart, November 1, 1999; 82(5): 589 - 593. [Abstract] [Full Text]
|
|
|
|
|
|
A. Di Lenarda, G. Sabbadini, L. Salvatore, G. Sinagra, L. Mestroni, B. Pinamonti, D. Gregori, F. Ciani, A. Muzzi, S. Klugmann, et al. Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol J. Am. Coll. Cardiol., June 1, 1999; 33(7): 1926 - 1934. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Kukin, J. Kalman, R. H. Charney, D. K. Levy, C. Buchholz-Varley, O. N. Ocampo, and C. Eng Prospective, Randomized Comparison of Effect of Long-Term Treatment With Metoprolol or Carvedilol on Symptoms, Exercise, Ejection Fraction, and Oxidative Stress in Heart Failure Circulation, May 25, 1999; 99(20): 2645 - 2651. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. S. Macdonald, A. M. Keogh, C. L. Aboyoun, M. Lund, R. Amor, and D. J. McCaffrey Tolerability and efficacy of carvedilol in patients with New York Heart Association class IV heart failure J. Am. Coll. Cardiol., March 15, 1999; 33(4): 924 - 931. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Carlson and K. Oberg Clinical Pharmacology of Carvedilol Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1999; 4(4): 205 - 218. [Abstract] [PDF]
|
|
|
|
 |
|
 W. H. Frishman Carvedilol N. Engl. J. Med., December 10, 1998; 339(24): 1759 - 1765. [Full Text] [PDF]
|
|
|
|
|
|
P. Lechat, M. Packer, S. Chalon, M. Cucherat, T. Arab, and J.-P. Boissel Clinical Effects of ß-Adrenergic Blockade in Chronic Heart Failure : A Meta-Analysis of Double-Blind, Placebo-Controlled, Randomized Trials Circulation, September 22, 1998; 98(12): 1184 - 1191. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Di Lenarda, R De Maria, A Gavazzi, D Gregori, M Parolini, G Sinagra, L Salvatore, F Longaro, E Bernobich, and F Camerini Long term survival effect of metoprolol in dilated cardiomyopathy Heart, April 1, 1998; 79(4): 337 - 344. [Abstract] [Full Text]
|
|
|
|
|
|
J E Sanderson, S K W Chan, C M Yu, L Y C Yeung, W M Chan, K Raymond, K W Chan, and K S Woo beta Blockers in heart failure: a comparison of a vasodilating beta blocker with metoprolol Heart, January 1, 1998; 79(1): 86 - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L Kukin, J. Kalman, M. M Mannino, C. Buchholz-Varley, and O. Ocampo beta Blockade in congestive heart failure: persistent adverse haemodynamic effects during chronic treatment with subsequent doses Heart, November 1, 1997; 78(5): 444 - 449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Sato, S. F. Vatner, Y.-T. Shen, R. K. Kudej, B. Ghaleh-Marzban, M. Uechi, K. Asai, I. Mirsky, T. A. Patrick, R. P. Shannon, et al. Effects of Cardiac Denervation on Development of Heart Failure and Catecholamine Desensitization Circulation, April 15, 1997; 95(8): 2130 - 2140. [Abstract] [Full Text]
|
|
|
|
|
|
L. Demopoulos, M. Yeh, M. Gentilucci, M. Testa, R. Bijou, S. D. Katz, D. Mancini, M. Jones, and T. H. LeJemtel Nonselective ß-Adrenergic Blockade With Carvedilol Does Not Hinder the Benefits of Exercise Training in Patients With Congestive Heart Failure Circulation, April 1, 1997; 95(7): 1764 - 1767. [Abstract] [Full Text]
|
|
|
|
|
|
K. Ogunyankin and B. N. Singh Reflections on Recent Clinical Trials in Patients With Heart Failure and Those With Reduced Ventricular Function Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1997; 2(3): 147 - 152. [PDF]
|
|
|
|
|
|
K. Chatterjee Heart Failure Therapy in Evolution Circulation, December 1, 1996; 94(11): 2689 - 2693. [Full Text]
|
|
|
|
|
|
M. Packer, W. S. Colucci, J. D. Sackner-Bernstein, C.-s. Liang, D. A. Goldscher, I. Freeman, M. L. Kukin, V. Kinhal, J. E. Udelson, M. Klapholz, et al. Double-Blind, Placebo-Controlled Study of the Effects of Carvedilol in Patients With Moderate to Severe Heart Failure: The PRECISE Trial Circulation, December 1, 1996; 94(11): 2793 - 2799. [Abstract] [Full Text]
|
|
|
|
|
|
W. S. Colucci, M. Packer, M. R. Bristow, E. M. Gilbert, J. N. Cohn, M. B. Fowler, S. K. Krueger, R. Hershberger, B. F. Uretsky, J. A. Bowers, et al. Carvedilol Inhibits Clinical Progression in Patients With Mild Symptoms of Heart Failure Circulation, December 1, 1996; 94(11): 2800 - 2806. [Abstract] [Full Text]
|
|
|
|
|
|
M. R. Bristow, E. M. Gilbert, W. T. Abraham, K. F. Adams, M. B. Fowler, R. E. Hershberger, S. H. Kubo, K. A. Narahara, H. Ingersoll, S. Krueger, et al. Carvedilol Produces Dose-Related Improvements in Left Ventricular Function and Survival in Subjects With Chronic Heart Failure Circulation, December 1, 1996; 94(11): 2807 - 2816. [Abstract] [Full Text]
|
|
|
|
|
|
E. M. Gilbert, W. T. Abraham, S. Olsen, B. Hattler, M. White, P. Mealy, P. Larrabee, and M. R. Bristow Comparative Hemodynamic, Left Ventricular Functional, and Antiadrenergic Effects of Chronic Treatment With Metoprolol Versus Carvedilol in the Failing Heart Circulation, December 1, 1996; 94(11): 2817 - 2825. [Abstract] [Full Text]
|
|
|
|
|
|
M. Packer, M. R. Bristow, J. N. Cohn, W. S. Colucci, M. B. Fowler, E. M. Gilbert, N. H. Shusterman, and The U.S. Carvedilol Heart Failure Study Group The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure N. Engl. J. Med., May 23, 1996; 334(21): 1349 - 1355. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Pfeffer and L. W. Stevenson {beta}-Adrenergic Blockers and Survival in Heart Failure N. Engl. J. Med., May 23, 1996; 334(21): 1396 - 1397. [Full Text]
|
|
|
|
 |
|
 J. D. Sackner-Bernstein and D. M. Mancini Rationale for Treatment of Patients With Chronic Heart Failure With Adrenergic Blockade JAMA, November 8, 1995; 274(18): 1462 - 1467. [Abstract] [PDF]
|
|
|
|
 |
|
 Beta Blocker Shows Promise for Severe Heart Failure Journal Watch Cardiology, November 1, 1995; 1995(1101): 3 - 3. [Full Text]
|
|
|
|
|
|
COMMITTEE MEMBERS, J. F. WILLIAMS Jr, M. R. BRISTOW, M. B. FOWLER, G. S. FRANCIS, A. GARSON Jr, B. J. GERSH, D. F. HAMMER, M. A. HLATKY, C. V. LEIER, et al. Guidelines for the Evaluation and Management of Heart Failure : Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure) Circulation, November 1, 1995; 92(9): 2764 - 2784. [Full Text]
|
|